Details of the Drug Formulaction

General Information of Drug Formulation (ID: F15500)

• Formulation Name: Norethindrone 0.35 mg tablet
• Company: Central Texas Community Health Centers

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Norethindrone	(DMTY169)	Solid tumour/cancer	2A00-2F9Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Sunset yellow FCF	(E00255)	17730	Colorant